Diversified Healthcare Trust Stock Price Target and Analyst Ratings (NASDAQ:DHC)

Analyst Price Target for DHC

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

^$4.40

▼ -2.22% Downside Potential

This price target is based on 6 analysts offering 12 month price targets for Diversified Healthcare Trust in the last 3 months. The average price target is $4.40, with a high forecast of $7.00 and a low forecast of $3.00. The average price target represents a -2.22% upside from the last price of $4.50.

Hold

The current consensus among 6 contributing investment analysts is to hold stock in Diversified Healthcare Trust. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
2 buy ratings
1 hold ratings
3 sell ratings

Ratings as of

9/7/2019

0 strong buy ratings
2 buy ratings
1 hold ratings
2 sell ratings

Ratings as of

12/6/2019

0 strong buy ratings
1 buy ratings
2 hold ratings
3 sell ratings

Ratings as of

3/5/2020

0 strong buy ratings
1 buy ratings
2 hold ratings
3 sell ratings

Ratings as of

6/3/2020

0 strong buy ratings
1 buy ratings
3 hold ratings
3 sell ratings

Ratings as of

9/1/2020

0 strong buy ratings
1 buy ratings
3 hold ratings
3 sell ratings

Ratings as of

11/30/2020

0 strong buy ratings
1 buy ratings
2 hold ratings
3 sell ratings

Ratings as of

1/29/2021

0 strong buy ratings
1 buy ratings
2 hold ratings
3 sell ratings

Ratings as of

2/28/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
2/2/2021	Morgan Stanley	Lower Price Target	Equal Weight	$5.00 ➝ $4.75	Low	i
12/10/2020	Wells Fargo & Company	Downgrade	Equal Weight ➝ Underweight	$4.00	High	i
11/16/2020	Bank of America	Boost Price Target	Underperform	$2.75 ➝ $3.25	Low	i
10/9/2020	Morgan Stanley	Boost Price Target	Equal Weight	$2.75 ➝ $3.00	Low	i
6/22/2020	Wells Fargo & Company	Boost Price Target	Equal Weight	$3.50 ➝ $4.00	Low	i
6/19/2020	Wells Fargo & Company	Reiterated Rating	Hold		Low	i
6/8/2020	JMP Securities	Initiated Coverage	Market Perform		High	i
5/19/2020	Morgan Stanley	Lower Price Target	Equal Weight	$8.00 ➝ $2.75	High	i
5/19/2020	Royal Bank of Canada	Lower Price Target	Underperform	$7.00 ➝ $3.00	High	i
5/11/2020	B. Riley	Lower Price Target	Buy	$10.00 ➝ $7.00	High	i
4/28/2020	Wells Fargo & Company	Reiterated Rating	Hold		High	i
3/9/2020	Royal Bank of Canada	Reiterated Rating	Sell	$7.00	High	i
3/4/2020	B. Riley	Lower Price Target	Buy	$12.00 ➝ $10.00	Medium	i
1/17/2020	Wells Fargo & Company	Downgrade	Overweight ➝ Equal Weight	$9.00	High	i
1/7/2020	Raymond James	Upgrade	Underperform ➝ Market Perform		Low	i
10/14/2019	Bank of America	Initiated Coverage	Underperform		Low	i
9/6/2019	Morgan Stanley	Initiated Coverage	Underweight ➝ Equal Weight	$8.50	Low	i Rating by Vikram Malhorta at Morgan Stanley
4/4/2019	B. Riley	Set Price Target	Buy	$14.00	Low	i Rating by Bryan Maher at B. Riley
4/2/2019	Royal Bank of Canada	Downgrade	Sector Perform ➝ Underperform	$8.00	High	i
3/28/2019	Morgan Stanley	Set Price Target	Sell	$11.00	Low	i Rating by Vikram Malhorta at Morgan Stanley
12/20/2018	(FBRC)	Set Price Target	Buy	$24.00	Low	i Rating by Bryan Maher at (FBRC)
12/3/2018	Wells Fargo & Company	Upgrade	Market Perform ➝ Outperform		Low	i
11/16/2018	Jefferies Financial Group	Downgrade	Hold ➝ Underperform		High	i
11/12/2018	B. Riley	Lower Price Target	Buy ➝ Buy	$23.00 ➝ $21.00	Medium	i Rating by Bryan Maher at B. Riley
11/6/2018	B. Riley	Set Price Target	Buy	$23.00	Low	i Rating by Bryan Maher at B. Riley
10/29/2018	Morgan Stanley	Downgrade	Equal Weight ➝ Underweight	$17.00 ➝ $15.00	Medium	i
8/8/2018	B. Riley	Boost Price Target	Buy ➝ Buy	$22.00 ➝ $23.00	Low	i Rating by Bryan Maher at B. Riley
7/20/2018	Jefferies Financial Group	Reiterated Rating	Hold		Low	i
5/9/2018	B. Riley	Set Price Target	Buy	$22.00	Low	i Rating by Bryan Maher at B. Riley
3/20/2018	Wells Fargo & Company	Lower Price Target	Underperform ➝ Underperform	$17.50 ➝ $16.00	Low	i
3/8/2018	Bank of America	Lower Price Target	Underperform ➝ Underperform	$16.50 ➝ $16.00	Low	i
3/1/2018	B. Riley	Set Price Target	Buy ➝ Buy	$24.00 ➝ $22.00	Medium	i Rating by Bryan Maher at B. Riley
2/28/2018	Robert W. Baird	Set Price Target	Hold	$17.00	Low	i Rating by Drew Babin at Robert W. Baird
2/28/2018	Cantor Fitzgerald	Lower Price Target	Overweight ➝ Overweight	$24.00 ➝ $21.00	Low	i
2/21/2018	Cantor Fitzgerald	Reiterated Rating	Buy		Low	i
1/24/2018	B. Riley	Set Price Target	Buy	$24.00	Low	i Rating by Bryan Maher at B. Riley
1/5/2018	Robert W. Baird	Reiterated Rating	Neutral ➝ Neutral	$20.00 ➝ $19.00	High	i
11/24/2017	Robert W. Baird	Reiterated Rating	Hold	$20.00	N/A	i
11/13/2017	B. Riley	Reiterated Rating	Buy	$24.00	N/A	i
11/3/2017	Robert W. Baird	Reiterated Rating	Hold	$21.00	N/A	i
11/1/2017	B. Riley	Reiterated Rating	Buy		N/A	i Rating by B. Maher at B. Riley
10/3/2017	Jefferies Financial Group	Reiterated Rating	Hold	$20.00	Low	i
10/2/2017	UBS Group	Lower Price Target	Neutral	$20.00 ➝ $19.00	Low	i
9/25/2017	Morgan Stanley	Boost Price Target	Equal Weight	$18.50 ➝ $19.50	Low	i
9/13/2017	Royal Bank of Canada	Reiterated Rating	Hold	$20.00	Low	i
7/24/2017	Royal Bank of Canada	Reiterated Rating	Hold	$22.00	Low	i
6/30/2017	(FBRC)	Reiterated Rating	Buy	$24.00	Low	i
6/19/2017	Royal Bank of Canada	Reiterated Rating	Hold	$22.00	Low	i
6/9/2017	Cantor Fitzgerald	Reiterated Rating	Buy	$24.00	Low	i
5/15/2017	Royal Bank of Canada	Downgrade	Outperform ➝ Sector Perform	$24.00 ➝ $22.00	High	i
5/12/2017	Jefferies Financial Group	Reiterated Rating	Hold	$21.00	Medium	i
5/8/2017	(FBRC)	Reiterated Rating	Buy		Low	i
3/10/2017	Robert W. Baird	Initiated Coverage	Neutral		Low	i
3/9/2017	Robert W. Baird	Initiated Coverage	Neutral ➝ Neutral	$20.00	Low	i
2/28/2017	Cantor Fitzgerald	Reiterated Rating	Buy	$24.00	N/A	i
1/3/2017	Royal Bank of Canada	Set Price Target	Buy	$24.00	N/A	i Rating by Michael A. Carroll at Royal Bank of Canada
12/28/2016	Cantor Fitzgerald	Initiated Coverage	Overweight	$23.00	N/A	i
12/21/2016	(FBRC)	Reiterated Rating	Outperform		N/A	i Rating by Maher. B at (FBRC)
12/21/2016	(FBRC)	Initiated Coverage	Outperform	$24.00	N/A	i
12/19/2016	Jefferies Financial Group	Reiterated Rating	Hold	$19.00	N/A	i
12/13/2016	Wells Fargo & Company	Downgrade	Market Perform ➝ Underperform		N/A	i
10/20/2016	Jefferies Financial Group	Downgrade	Buy ➝ Hold	$25.00 ➝ $23.00	N/A	i
8/22/2016	Jefferies Financial Group	Boost Price Target	Buy	$24.00 ➝ $25.00	N/A	i Rating by Omotayo Okusanya at Jefferies Financial Group Inc.
6/17/2016	Royal Bank of Canada	Upgrade	Sector Perform ➝ Outperform	$18.00 ➝ $23.00	N/A	i
6/8/2016	UBS Group	Reiterated Rating	Neutral	$15.00 ➝ $18.00	N/A	i
3/14/2016	Jefferies Financial Group	Boost Price Target	Buy	$17.00 ➝ $19.00	N/A	i

(Data available from 3/1/2016 forward)

DHC is a real estate investment trust, or REIT, that owns medical office and life science properties, senior living communities and wellness centers throughout the United States. DHC is managed by the operating subsidiary of The RMR Group Inc., an alternative asset management company that is headquartered in Newton, MA.

Today's Range

Now: $4.50

$4.50

$4.81

50 Day Range

MA: $4.40

$4.02

$4.82

52 Week Range

Now: $4.50

$2.00

$7.28

Volume

1,915,700 shs

Average Volume

1,245,529 shs

Market Capitalization

$1.07 billion

P/E Ratio

N/A

Dividend Yield

0.89%

Beta

1.37

Frequently Asked Questions

What sell-side analysts currently cover shares of Diversified Healthcare Trust?

The following Wall Street sell-side analysts have issued reports on Diversified Healthcare Trust in the last year: B. Riley, Bank of America Co., JMP Securities, Morgan Stanley, Royal Bank of Canada, TheStreet, Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for DHC.

What is the current price target for Diversified Healthcare Trust?

5 Wall Street analysts have set twelve-month price targets for Diversified Healthcare Trust in the last year. Their average twelve-month price target is $4.40, suggesting a possible downside of 2.2%. B. Riley has the highest price target set, predicting DHC will reach $7.00 in the next twelve months. Royal Bank of Canada has the lowest price target set, forecasting a price of $3.00 for Diversified Healthcare Trust in the next year.
View the latest price targets for DHC.

What is the current consensus analyst rating for Diversified Healthcare Trust?

Diversified Healthcare Trust currently has 3 sell ratings, 2 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in DHC, but not buy more shares or sell existing shares.
View the latest ratings for DHC.

What other companies compete with Diversified Healthcare Trust?

Other companies that are similar to Diversified Healthcare Trust include American Tower, Public Storage, Welltower, Weyerhaeuser, Ventas, Extra Space Storage, Medical Properties Trust, Omega Healthcare Investors, CubeSmart, Life Storage, Rayonier, Ryman Hospitality Properties, Healthcare Realty Trust, Sabra Health Care REIT and PotlatchDeltic.

How do I contact Diversified Healthcare Trust's investor relations team?

Diversified Healthcare Trust's physical mailing address is Two Newton Place 255 Washington Street Suite 300, NEWTON MA, 02458. The real estate investment trust's listed phone number is 617-796-8350 and its investor relations email address is [email protected] The official website for Diversified Healthcare Trust is www.dhcreit.com.

NASDAQ:DHC - Diversified Healthcare Trust Stock Price Target and Predictions

Analyst Price Target for DHC

Past Monthly Recommendations

Latest Recommendations

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Diversified Healthcare Trust?

What is the current price target for Diversified Healthcare Trust?

What is the current consensus analyst rating for Diversified Healthcare Trust?

What other companies compete with Diversified Healthcare Trust?

How do I contact Diversified Healthcare Trust's investor relations team?